Publication Date :
August 31, 2006 |
|
CA Inc |
Recommendations - US Standard Policy |
|
|
Item |
Code*
Proposal |
Mgt.
Rec. |
ISS Rec. |
1.1
|
M0201
Elect Director Alfonse M. D'Amato |
FOR |
WITHHOLD |
1.2
|
M0201
Elect Director Gary J. Fernandes |
FOR |
FOR |
1.3
|
M0201
Elect Director Robert E. La Blanc |
FOR |
FOR |
1.4
|
M0201
Elect Director Christopher B. Lofgren |
FOR |
FOR |
1.5
|
M0201
Elect Director Jay W. Lorsch |
FOR |
FOR |
1.6
|
M0201
Elect Director William E. McCracken |
FOR |
FOR |
1.7
|
M0201
Elect Director Lewis S. Ranieri |
FOR |
FOR |
1.8
|
M0201
Elect Director Walter P. Schuetze |
FOR |
FOR |
1.9
|
M0201
Elect Director John A. Swainson |
FOR |
FOR |
1.10 |
M0201
Elect Director Laura S. Unger |
FOR |
FOR |
1.11
|
M0201
Elect Director Ron Zambonini |
FOR |
FOR |
2
|
M0101
Ratify Auditors |
FOR |
FOR |
3
|
S0332
Amend Terms of Existing Poison Pill |
AGAINST |
FOR |
*S
indicates shareholder proposal |
|
*** |
|
|
[Pages 6-7]
Items 1.1-1.11:
Elect Directors |
SPLIT |
The Corporate Governance
Committee serves as the nominating committee.
Board Independence
A substantial majority of
the board members are independent outsiders. The key board committees
include no insiders or affiliated outsiders.
Option Backdating
Issue
Option backdating has
serious implications and in some cases have resulted in financial
restatements, delisting of companies or termination of executives or
directors. Institutional investors are deeply concerned when there is an
option backdating allegation. In this case, CA started an internal
investigation on its option grant practices and found that certain option
grants made between 1996 to 2001 had not been communicated to employees in a
timely manner. As a result, CA reported that it will recognize additional
stock-based compensation expense of $342 million on a pretax basis.
As disclosed in the
company's 10-K, prior to fiscal year 2002, the Stock Option and Compensation
Committee generally approved grants to executives and other employees
receiving options, the terms of which were generally set on the date that
the Committee acted, including the exercise price, vesting schedule and
term. However, in a number of cases, these approvals involved pools of
options that were not allocated to specific individuals at the time of such
approvals. It also appears that communication of these grants by management
to individual employees was not made until some time after the Committee
acted, including in some cases up to two years after such Committee action.
In almost all cases, this earlier date had an exercise price that was lower
than the market price of the company’s common stock on the date the award
was formally communicated to employees. The grants which were not
communicated on a timely basis were made primarily to non-executive
employees and this grant practice was changed after fiscal year 2001.
In response to the above
issue, the company stated that the problem was not option backdating but
delayed communication of grants to employees by management, following the
Stock Option and Compensation Committee's authorization of the grants,
during fiscal years prior to 2002. The company's internal review did not
find any deficiencies in its internal controls and procedures with respect
to the granting of options during fiscal 2002 through fiscal year 2006. The
company believes that its current policies and procedures with respect to
the granting of options are sound.
ISS has concerns with the
internal controls and procedures of option grants prior to 2002. The
duration of the misdated options is five years and the magnitude of
restatement is approximately 9% of 2005 revenue. ISS is concerned that the
board would approve option grants that were not allocated to specific
individuals. While the company's current practice is to communicate promptly
after an option grant is approved by the Committee, the company has not
adopted any option grant practices to prevent any misdating or timing of
options in the future. ISS recommends a vote to WITHHOLD from members of the
compensation committee who failed to provide adequate oversight to the
option grant process for the concerned period. Several Compensation
Committee members are no longer present on the board with the exception of
director nominee, Alfonse M. D'Amato. Mr. D'Amato joined the board towards
the end of fiscal year 1999 and was part of the Stock Option and
Compensation Committee in 2000.
ISS recommends voting FOR
all directors with the exception of Alfonse M. D'Amato for not providing
adequate oversight on the approval process of stock options in 2000.
Vote FOR Items
1.2-1.11.
WITHHOLD a vote on Item 1.1. |
US
Standard Policy |
***
One, or more, of the
proponents of a shareholder proposal at the upcoming meeting may be a client
of ISS or the parent of, or affiliated with, a client of ISS. None of the
sponsors of the shareholder proposal(s) played a role in preparing this
report.
Two of ISS' stockholders,
Warburg Pincus Private Equity VIII, L.P. and Hermes USA Investors Venture,
L.L.C., are institutional investors whose business activities include making
equity and debt investments in public and privately-held companies. As a
result, from time to time one or more of ISS' stockholders or their
affiliates (or their representatives who serve on ISS' Board of Directors)
may hold securities, serve on the board of directors and/or have the right
to nominate representatives to the board of a company which is the subject
of one of ISS' proxy analyses and vote recommendations. We have established
policies and procedures to restrict the involvement of ISS' non-management
stockholders, their affiliates and board members in the editorial content of
our analyses and vote recommendations.
Institutional Shareholder
Services Europe SA ("ISS Europe") is a wholly-owned subsidiary of ISS.
Jean-Nicolas Caprasse, the managing director of ISS Europe, is a
non-executive partner of Deminor International SCRL ("International"), a
company which provides active engagement and other advisory services to
shareholders of both listed and non-listed companies. As a result,
International may be providing engagement services to shareholders of a
company which is the subject of one of our analyses or recommendations or
otherwise working on behalf of shareholders with respect to such a company.
As a non-executive partner of International, Mr. Caprasse is not involved in
the engagement and other services provided to the clients of International.
International has no role in the formulation of the research policies,
reports and vote recommendations prepared by ISS or ISS Europe. Mr. Caprasse
will benefit financially from the success of International's business in
proportion to his partnership interest.
Neither ISS'
non-management stockholders, their affiliates nor ISS' non-management board
members are informed of the contents of any of our analyses or
recommendations prior to their publication or dissemination.
CA Inc
August 31, 2006
© 2006, Institutional
Shareholder Services Inc. All Rights Reserved. The information contained in
this ISS Proxy Analysis may not be republished, broadcast, or redistributed
without the prior written consent of Institutional Shareholder Services Inc. |